Goldman Sachs Maintains Monsanto Company to Sell with Price Target $83.00

Brokerage firm Goldman Sachs Maintains its rating on Monsanto Company(NYSE:MON). In a research note issued to the investors, the brokerage major Lowers the price-target to $83.00 per share. The shares have been rated Sell. The rating by Goldman Sachs was issued on Apr 11, 2016.

In a different note, On Mar 14, 2016, Citigroup said it Downgrades its rating on Monsanto Company. In the research note, the firm Lowers the price-target to $105.00 per share. The shares have been rated ‘Hold’ by the firm. On Mar 4, 2016, Goldman Sachs said it Downgrades its rating on Monsanto Company. In the research note, the firm Lowers the price-target to $86.00 per share. The shares have been rated ‘Sell’ by the firm. On Mar 3, 2016, Veritical Research said it Downgrades its rating on Monsanto Company. The shares have been rated ‘Hold’ by the firm. On Mar 3, 2016, Deutsche Bank said it Maintains its rating on Monsanto Company. In the research note, the firm Lowers the price-target to $110.00 per share. The shares have been rated ‘Buy’ by the firm. On Mar 2, 2016, Credit Suisse said it Maintains its rating on Monsanto Company. In the research note, the firm Lowers the price-target to $109.00 per share. The shares have been rated ‘Outperform’ by the firm.

Monsanto Company (MON) shares turned negative on Fridays trading session with the shares closing down -0.58 points or -0.65% at a volume of 37,10,982. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $88.75. The peak price level was also seen at $88.75 while the days lowest was $85.92. Finally the shares closed at $88.37. The 52-week high of the shares is $123.82 while the 52-week low is $81.22. According to the latest information available, the market cap of the company is $38,604 M.

Monsanto Company(MON) last announced its earnings results on Jan 6, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $2.22B. Analysts had an estimated revenue of $2.39B. Earnings per share were $-0.11. Analysts had estimated an EPS of $-0.23.

Several Insider Transactions has been reported to the SEC. On Nov 30, 2015, Kerry J Preete (EVP, Global Strategy) sold 30 shares at $95.97 per share price.Also, On Oct 23, 2015, William U Parfet (director) sold 17,000 shares at $91.16 per share price.On Oct 15, 2015, Steven Mizell (Exec. VP Human Resources) sold 6,100 shares at $89.40 per share price, according to the Form-4 filing with the securities and exchange commission.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.